PIL - Imatinib Accord 100 mg, 400 mg Film-coated Tablets: Change history
View Patient Information Leaflet (PIL - Imatinib Accord 100 mg, 400 mg Film-coated Tablets)
Last updated on this site: 05 Nov 2024
1)To register a change in the composition of the finished
product by changing the tablet coating from Hypromellose 6
cps (E464) to Polyvinyl alcohol- (E1203) and from Polyethylene
glycol to Polyethylene glycol (E1521). Consequently, section
6.1 of the SmPC and the PIL has been updated.
2)To register a minor change in manufacturing process of
finished product by changing the manufacturing process for
coating solution preparation from non-aqueous coating solution to aqueous coating solution.
3)To register a change in the specification parameters of the
finished product by deletion of residual solvent test for
Dichloromethane from finished product specification.
Last updated on this site: 05 Nov 2024
1)To register a change in the composition of the finished
product by changing the tablet coating from Hypromellose 6
cps (E464) to Polyvinyl alcohol- (E1203) and from Polyethylene
glycol to Polyethylene glycol (E1521). Consequently, section
6.1 of the SmPC and the PIL has been updated.
2)To register a minor change in manufacturing process of
finished product by changing the manufacturing process for
coating solution preparation from non-aqueous coating solution to aqueous coating solution.
3)To register a change in the specification parameters of the
finished product by deletion of residual solvent test for
Dichloromethane from finished product specification.
-
Changes: (Updated: 05 Nov 2024)
1)To register a change in the composition of the finished
product by changing the tablet coating from Hypromellose 6
cps (E464) to Polyvinyl alcohol- (E1203) and from Polyethylene
glycol to Polyethylene glycol (E1521). Consequently, section
6.1 of the SmPC and the PIL has been updated.
2)To register a minor change in manufacturing process of
finished product by changing the manufacturing process for
coating solution preparation from non-aqueous coating solution to aqueous coating solution.
3)To register a change in the specification parameters of the
finished product by deletion of residual solvent test for
Dichloromethane from finished product specification.
-
Changes: (Updated: 15 Aug 2024)
To update sections 4.4, 5.1 and 5.2 of the SmPC in line with reference product, Glivec (MAH: Novartis Europharm Limited, Ireland). Consequently, the PIL has been updated.
-
Changes: (Updated: 17 Oct 2023)
Description of update:
1. To register the addition of a new pack size of Alu/Alu-blister pack of 30s (30 x 1) for the finished product
2. To register the addition of a new pack size of Alu/Alu-blister pack of 60s (60 x 1) for the finished product.
3. To register the addition of a new pack size of Alu/Alu-blister pack of 90s (90 x 1) for the finished product.
4. To register the addition of a new pack size of Alu/Alu-blister pack of 120s (120 x 1) for the finished product.
5. To register the addition of a new pack size of Alu/Alu-blister pack of 180s (180 x 1) for the finished product.
PIL sections updated: 6.
-
Changes: (Updated: 20 Sep 2022)
Initial upload